- Home
- CPBI vs HOWL Comparison
CPBI vs HOWL Comparison
Compare CPBI & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- HOWL
- Stock Information
- Founded
- CPBI 2023
- HOWL 2017
- Country
- CPBI United States
- HOWL United States
- Employees
- CPBI N/A
- HOWL N/A
- Industry
- CPBI
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- HOWL Health Care
- Exchange
- CPBI Nasdaq
- HOWL Nasdaq
- Market Cap
- CPBI 56.2M
- HOWL 50.2M
- IPO Year
- CPBI N/A
- HOWL 2021
- Fundamental
- Price
- CPBI $15.00
- HOWL $1.07
- Analyst Decision
- CPBI
- HOWL Strong Buy
- Analyst Count
- CPBI 0
- HOWL 3
- Target Price
- CPBI N/A
- HOWL $9.00
- AVG Volume (30 Days)
- CPBI 9.6K
- HOWL 252.4K
- Earning Date
- CPBI 01-01-0001
- HOWL 03-11-2025
- Dividend Yield
- CPBI N/A
- HOWL N/A
- EPS Growth
- CPBI 29.70
- HOWL N/A
- EPS
- CPBI 1.62
- HOWL N/A
- Revenue
- CPBI $18,546,000.00
- HOWL $1,885,000.00
- Revenue This Year
- CPBI N/A
- HOWL $36.45
- Revenue Next Year
- CPBI N/A
- HOWL $296.58
- P/E Ratio
- CPBI $9.11
- HOWL N/A
- Revenue Growth
- CPBI 13.73
- HOWL N/A
- 52 Week Low
- CPBI $9.96
- HOWL $1.03
- 52 Week High
- CPBI $15.50
- HOWL $6.89
- Technical
- Relative Strength Index (RSI)
- CPBI 63.67
- HOWL 34.43
- Support Level
- CPBI $14.80
- HOWL $1.05
- Resistance Level
- CPBI $14.81
- HOWL $1.18
- Average True Range (ATR)
- CPBI 0.08
- HOWL 0.08
- MACD
- CPBI 0.02
- HOWL -0.00
- Stochastic Oscillator
- CPBI 100.00
- HOWL 20.33
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.